Are Bilcare Ltd latest results good or bad?

1 hour ago
share
Share Via
Bilcare Ltd's latest results show a net profit of ₹13.37 crores, a significant improvement from the previous quarter, but a decline compared to last year, indicating ongoing challenges. While operational efficiency has improved, concerns remain due to high debt and reliance on non-operating income, suggesting the financial health is still precarious.
Bilcare Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant contrasts. The company reported a consolidated net profit of ₹13.37 crores, which reflects a substantial quarter-on-quarter increase, reversing losses from the previous quarter. However, this profit is down compared to the same quarter last year, indicating ongoing challenges in maintaining consistent profitability.
Net sales for the quarter reached ₹187.66 crores, marking a modest sequential growth of 3.50% from the previous quarter, but this also represents a year-on-year decline of 3.28%. This trend suggests that while there is some recovery in sales, the company is struggling to regain the momentum it previously enjoyed, as evidenced by sales figures that have not returned to levels above ₹200 crores seen in earlier periods. The operating margin, excluding other income, improved to 9.02%, the highest in eight quarters, indicating enhanced operational efficiency and cost management. However, the reliance on other income, which constituted a significant portion of the profit before tax, raises concerns about the sustainability of these earnings. The company’s return on equity remains negative at -3.67%, highlighting ongoing issues with capital efficiency and shareholder value creation. Bilcare's balance sheet shows a high debt burden, with a debt-to-equity ratio that remains concerning. The company's operational challenges are compounded by a lack of institutional investor confidence, as indicated by negligible institutional holdings. Overall, while Bilcare Ltd has shown some operational improvements in the latest quarter, the underlying financial health remains precarious, with persistent debt issues and reliance on non-operating income casting doubt on the sustainability of its recent profit turnaround. The company saw an adjustment in its evaluation, reflecting these ongoing challenges and the mixed signals from its financial performance.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News